| Company |
Products or services |
| Liquidia Technologies |
PRINT particle design for vaccines; fluoropolymer materials |
| Leonardo Biosystems |
Entered into a partnership with NanoMedical Systems mentioned below to manufacture nanoporous silicon particles for Leonardo's multi-stage drug delivery system |
| NanoMedical Systems |
Drug Delivery Devices or Systems: PMDS-1, PMDS-2+ |
| Imbio |
Parametric Response Mapping (PRM) |
| Forma Therapeutics |
Drug discovery services |
| Foundation Medicine |
FoundationOneTM genomic profile assay |
| Integrated Diagnostics Inc |
Protein-Catalyzed Capture Agents |
| H3 Biomedicine |
Formed strategic partnership with Compendia 02-2012 to license and offer Compendia's full suite of oncology data mining tools including Oncomine Concepts Edition and Oncomine Power Tools Edition |
| Oncovance Technologies Inc |
KattanNomograms |
| T2 Biosystems |
T2Dx, T2Hemostasis machines which utilize the T2 Magnetic Resonance (T2MR) technology allows for direct detection in complex matrices |
| Combinent Biomedical Systems |
Transvaginal drug delivery vaginal ring for reproductive endocrinology |
| Momenta Pharmaceuticals |
Enoxaparin Sodium Injection (generic Lovenox), M356 (generic Copaxone) |
| Pervasis Therapeutics |
Vascugel® for hemodialysis, PVS-10200 for the treatment of PAD, PVS-30200 for oncology |
| Pulmatrix |
Dry Powder iCALM for COPD, Asthma, and respiratory infections |
| Living Proof |
>25 (anti-frizz technology beauty products) |
| Arsenal Vascular (medical) |
AxioCoreTM nanofiber drug delivery technology |
| InVivo Therapeutics |
Biopolymer scaffolding to treat spinal cord injuries (SCI) |
| SemprusBioSciences |
Semprus SustainTM Technology* which is a long-lasting, covalently bonded, non-leaching polymer that is designed to reduce the attachment of platelets and blood proteins at the device surface. |
| BIND Biosciences |
AccurinsTM: BIND-014, chemotherapeutics |
| Selecta Biosciences |
SVP™ platform, tSVPTM - fully-integrated synthetic nanoparticle vaccines engineered to mimic the properties of natural pathogens to elicit a maximal immune response, t2SVPTM - designed to induce an antigen-specific immune tolerance |
| Seventh Sense Biosystems |
TAP Touch Activated PhlebotomyTM, TAP 20 |
| TARIS BioMedical |
LiRIS to treat the pain and discomfort associated with Interstitial Cystitis (IC) and ureteral stent symptoms |
| Kala Pharmaceuticals |
Mucosal Penetrating Products (MPPs) |
| ModeRNA Therapeutics |
RNA-based drugs, explore modified mRNA to create a new class of drugs, nativeTM protein therapeutics. |
| Blend Therapeutics |
MaestroTM platform: long-circulating nanoparticles |
| 480 Biomedical |
The StanzaTM Bioresorbable Scaffold |
| NanoInk |
>30 (nanolithography, bioarrays, advanced materials, repair, instrumentation) |
| Nanosphere |
15-20(Clinical Microbiology Tests, Cardiac Tests, Human Genetic Tests, Pharmacogenetic Tests, Instruments) |
| AuraSense Therapeutics |
SNATM Gene Regulation Platform |
